picture of FDA Consumer Magazine logo


VOL. 33   NO. 5blank spaceSEPTEMBER-OCTOBER 1999


Features

When Is a Medical Product Too Risky?
Following the recent withdrawal of several prescription drugs from the market because of adverse effects, consumers may wonder, how safe are approved drugs and other medical products? Safer than ever, says the director of FDA's drug center.

Campylobacter: Low-Profile Bug Is Food Poisoning Leader
Though not exactly a household word, Campylobacter causes millions of cases of food-borne illness every year. FDA is working to stem widespread contamination in poultry and increasing resistance to antibiotics.

Keeping Food Safety Surveys Honest
Telephone surveys can give researchers valuable insights into consumer food habits. But how reliable are these data? FDA is putting consumers in front of the camera to find out.

When Machines Do the Breathing
Like the iron lungs of the past, ventilators take over for the lungs in seriously ill or injured patients. But, unlike the past, today's devices are much smaller and many can be used in the home.

Crohn's Disease: New Drug May Help When Others Fail
A new drug can reduce the symptoms of this incurable and debilitating intestinal inflammation.

Taking Time to Use Medicines Wisely
Amid busy schedules, women may sometimes cut corners when taking medications, causing potential hazards. FDA's Take Time To Care program urges women to slow down and focus on their own health.


Departments

Updates
The latest information on FDA-related issues, gathered from FDA Press Releases, Talk Papers, and other sources.

fda.gov
Places of interest on FDA's Website and other government and health-related sites.

Investigators' Reports
Selected cases illustrating regulatory and administrative actions--such as inspections, recalls, seizures, and court proceedings--by FDA's regional and district offices across the country

Summaries of Court Actions
Cases involving seizure, criminal and injunction proceedings.


How to Subscribe   |   Back Issues   |   Publications Catalog   |   FDA Home Page


Questions concerning the editorial content of FDA Consumer should be directed to FDA's Office of Public Affairs.

Hypertext created by clb 1999-AUG-10.